# US 2016/0355548 A1 · Tumor-targeting polypeptide and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355548 A1
- Document ID: US20160355548A1
- Status: Published application
- Kind: A1
- Application number: 15/021,366
- Filed: 2014-09-05
- Published: 2016-12-08
- Earliest claimed: 2013-09-11
- Assignees: Sun Yat-Sen University Cancer Center
- Applicants: Sun Yat-Sen University Cancer Center
- Inventors: Musheng Zeng; Xing Zhang; Jun Wang; Guokai Feng; Mengqing Zhang; Qian Zhong
- Web page: https://patentgrep.com/patent/US20160355548A1

## CPC

- C07K 7/06: having 5 to 11 amino acids
- A61K 47/64: Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K47/65)
- A61K 49/0056: {Peptides, proteins, polyamino acids}
- A61K 51/08: Peptides, e.g. proteins {, carriers being peptides, polyamino acids, proteins}
- A61K 51/088: {conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10)}
- A61P 35/00: Antineoplastic agents
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention provides a tumor-targeting peptide. This tumor-targeting peptide comprises a typical motif with the general formula of: XX(Y/F) (D/E) (D/E) XX. The motif is selectively connected with 1-3 amino acids at the C-terminal and/or N-terminal. X represents any one of the twenty natural amino acids or the D type amino acids. The present invention also discloses that the peptide can not only target tumor vessels and tumor cells but also penetrate them and thus can be applied in tumor diagnosis and therapy.

## Claims

### Claim 1

A tumor-targeting peptide, comprising
a motif having a general formula of: XX(Y/F)(D/E)(D/E)XX,
wherein, a C-terminal, an N-terminal, or both the C and N terminals of the motif are selectively connected to 1-3 amino acids, and
wherein X represents any one of the twenty natural amino acids or the D type amino acid thereof.

### Claim 2 (depends on 1)

The tumor-targeting peptide according to claim 1, wherein the general formula of the motif is: XXYDEXX.

### Claim 3 (depends on 1)

The tumor-targeting peptide according to claim 1, wherein the tumor-targeting peptide is cyclized by the terminal amino acids.

### Claim 4 (depends on 1)

The tumor-targeting peptide according to claim 1, wherein two ends of the peptide may be connected with one Cys, respectively.

### Claim 5 (depends on 1)

The tumor-targeting peptide according to claim 1, wherein the motif of the tumor-targeting peptide is RWYDENA.

### Claim 6 (depends on 1)

A method for diagnosing a tumor, the method comprising:
diagnosing tumor cells with a tumor diagnosis reagent comprising a tumor-targeting peptide according to claim 1.

### Claim 7 (depends on 1)

A method of tumor-targeting drug administration comprising:
administering a tumor-targeting peptide according to claim 1 coupled with an anti-tumor drug.

### Claim 8 (depends on 1)

A pharmaceutical composition comprising:
a tumor-targeting peptide according to claim 1 coupled with an anti-tumor drug.
